Sugimoto K et al. |
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. |
2019 |
Dig Dis |
pmid:30205400
|
Kim JP et al. |
The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model. |
2018 |
Microsurgery |
pmid:28792625
|
Min S et al. |
A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation. |
2018 |
Pediatr Transplant |
pmid:30178515
|
La Maestra S et al. |
Brain microglia activation induced by intracranial administration of oligonucleotides and its pharmacological modulation. |
2018 |
Drug Deliv Transl Res |
pmid:29869293
|
Zhang T et al. |
Association of donor small ubiquitin-like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after liver transplantation. |
2018 |
Liver Int. |
pmid:28941036
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Bittersohl H et al. |
A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. |
2018 |
J Chromatogr A |
pmid:29544893
|
Li X et al. |
Association of the PPARγ/PI3K/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic/reperfusion injury. |
2018 |
Mol Med Rep |
pmid:29488613
|
Takeuchi T et al. |
Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan. |
2018 |
Mod Rheumatol |
pmid:28649878
|
Li YM et al. |
Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study. |
2018 |
Int. Immunopharmacol. |
pmid:29310109
|